Q2 EPS Forecast for Phibro Animal Health Boosted by Analyst

Phibro Animal Health Co. (NASDAQ:PAHC) – Analysts at Zacks Research lifted their Q2 2026 earnings estimates for shares of Phibro Animal Health in a research note issued on Tuesday, January 7th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.49 for the quarter, up from their prior forecast of $0.47. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.62 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q3 2026 earnings at $0.36 EPS, Q4 2026 earnings at $0.50 EPS, FY2026 earnings at $1.66 EPS and FY2027 earnings at $2.12 EPS.

Several other equities research analysts have also commented on PAHC. StockNews.com raised Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 4th. Morgan Stanley boosted their target price on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Finally, Barclays raised their price target on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research report on Tuesday, November 12th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Phibro Animal Health has an average rating of “Hold” and a consensus price target of $20.50.

Phibro Animal Health Trading Down 6.7 %

Shares of PAHC opened at $20.05 on Thursday. Phibro Animal Health has a twelve month low of $10.03 and a twelve month high of $25.98. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. The firm has a market capitalization of $812.09 million, a P/E ratio of 46.63, a PEG ratio of 0.58 and a beta of 0.53. The firm’s 50-day moving average is $22.75 and its two-hundred day moving average is $21.08.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.39%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio is presently 111.63%.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. Quantbot Technologies LP purchased a new stake in shares of Phibro Animal Health during the third quarter worth about $70,000. nVerses Capital LLC acquired a new stake in Phibro Animal Health during the third quarter worth approximately $70,000. China Universal Asset Management Co. Ltd. grew its stake in Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after acquiring an additional 1,522 shares during the period. CWM LLC raised its holdings in Phibro Animal Health by 190.8% in the 3rd quarter. CWM LLC now owns 6,363 shares of the company’s stock valued at $143,000 after acquiring an additional 4,175 shares during the last quarter. Finally, Algert Global LLC purchased a new position in shares of Phibro Animal Health during the 2nd quarter worth $193,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.